Approval based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to placebo In the EU, there are approximately 270,000 adults and adolescents aged 12 years ...

Approval based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to placebo In the EU, there are ...

Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria Approval ...

As biologic options have expanded for the treatment of chronic spontaneous urticaria (CSU), the question of which one works best has gained importance.

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

WEDNESDAY, Oct. 29, 2025 (HealthDay News) — An anti-inflammation injectable drug can reduce mucus buildup and improve breathing among asthma patients, a new clinical trial says. The drug dupilumab ...

A man with asthma, an Asian man at home sitting on the couch breathing in an inhaler An anti-inflammation injectable can help asthma patients with airways clogged by mucus The number of patients with ...

(Stacker) - Thinking about starting a family—or already expecting? You’re not alone in asking the big question: Can we actually afford this? The average cost to raise a child to age 18 is now ...

In 2025, managing costs is one of the top priorities for logistics businesses across the country. With the reality of tariffs biting, freight firms are under pressure to make every cent count. But how ...